Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0. This indicates a small backend or content metadata update without changing study content or user-facing actions.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows a recruitment-status note indicating the study is not enrolling. It also adds new help/navigation items (e.g., 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and includes minor formatting updates (Intervention/Treatment) along with a revision badge update to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedRevision: v3.5.5 was added to the site footer. The related topics section was trimmed by removing Melanoma, MedlinePlus Genetics, and the Revision: v3.5.4 entry.SummaryDifference0.1%

- Check39 days agoChange DetectedA Melanoma label and a related topics entry for MedlinePlus Genetics were added to the page, enhancing topic tagging and linking to consumer health resources. This helps users discover related information about the condition more easily.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance release. This does not modify the displayed study details.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page’s revision/version indicator was updated (to v3.5.3), reflecting a site update rather than a change to the clinical study information. Some generic related-topics/navigation labels (including a previous revision reference) were removed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.